ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,051Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 1571

$560K Total Retail Price of All Prescriptions

Rank: 189 out of 1571

268 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 268 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 268 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 8,930 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
DONEPEZIL HCL 445 433 1 24
HYDROCODONE-ACETAMINOPHEN 389 334 S3 2 3
AMLODIPINE BESYLATE 326 287 3 2
DIVALPROEX SODIUM 326 274 3 122
LEVOTHYROXINE SODIUM 295 247 5 6
OMEPRAZOLE 287 242 6 4
METFORMIN HCL 275 226 7 9
FUROSEMIDE 265 260 8 7
QUETIAPINE FUMARATE 255 183 9 102
LISINOPRIL 249 203 10 5
SIMVASTATIN 236 195 11 1
TRAZODONE HCL 211 146 12 74
FAMOTIDINE 205 168 13 54
NAMENDA 199 199 14 37
RISPERIDONE 162 146 15 89
POTASSIUM CHLORIDE 151 149 16 27
MIRTAZAPINE 142 142 17 96
OXYCODONE HCL-ACETAMINOPHEN 139 61 S2 18 165
WARFARIN SODIUM 137 73 19 14
GABAPENTIN 133 97 20 12
NOVOLIN R 131 127 21 256
HUMULIN R 129 112 22 309
CARVEDILOL 129 104 22 10
ATENOLOL 125 106 24 15
LEVETIRACETAM 124 59 25 60
IPRATROPIUM-ALBUTEROL 120 116 26 274
MEGESTROL ACETATE 114 114 R 27 145
METOPROLOL TARTRATE 112 95 28 13
SEROQUEL 108 86 29 270
IBUPROFEN 107 82 30 44
CARBAMAZEPINE 107 0 30 193
LANTUS 107 105 30 65
ENALAPRIL MALEATE 106 71 33 81
ALENDRONATE SODIUM 105 74 34 22
GLIPIZIDE 102 97 35 53
NORTRIPTYLINE HCL 95 95 36 212
GLYBURIDE 92 92 R 37 99
TAMSULOSIN HCL 91 61 38 11
LAMOTRIGINE 91 0 38 118
FLUOXETINE HCL 87 68 40 112
PAROXETINE HCL 87 63 40 100
CLOPIDOGREL 83 72 42 21
ALBUTEROL SULFATE 79 78 43 166
CLONIDINE HCL 78 50 44 45
VALPROIC ACID 78 59 44 441
PHENYTOIN SODIUM EXTENDED 78 45 44 194
CEPHALEXIN 67 57 47 126
BENZTROPINE MESYLATE 65 61 R 48 170
NIFEDIPINE ER 65 44 48 78
HYDROCHLOROTHIAZIDE 61 45 50 18
DIGOXIN 61 51 50 35
BENAZEPRIL HCL 60 47 52 32
OLANZAPINE 59 53 53 173
PLAVIX 59 48 53 28
NOVOLOG 59 59 53 226
LACTULOSE 57 54 56 196
SERTRALINE HCL 56 56 57 52
ZOLPIDEM TARTRATE 54 25 58 20
CITALOPRAM HBR 52 39 59 66
LEVOFLOXACIN 52 51 59 79
AMIODARONE HCL 51 40 61 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.